diallyl trisulfide has been researched along with Adjuvant Arthritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, DG; Chen, Y; Li, HR; Liang, JJ; Liang, ZC; Shi, YQ; Xin, L; Zhang, C; Zhang, LL; Zhao, DB | 1 |
1 other study(ies) available for diallyl trisulfide and Adjuvant Arthritis
Article | Year |
---|---|
Diallyl Trisulfide can induce fibroblast-like synovial apoptosis and has a therapeutic effect on collagen-induced arthritis in mice via blocking NF-κB and Wnt pathways.
Topics: Aged; Allyl Compounds; Animals; Antirheumatic Agents; Apoptosis; Arthritis, Experimental; Arthritis, Rheumatoid; Cells, Cultured; Disease Models, Animal; Female; Fibroblasts; Humans; Male; Mice; Mice, Inbred DBA; Middle Aged; NF-kappa B; Signal Transduction; Sulfides; Synovial Membrane; T-Lymphocytes, Regulatory; Th17 Cells; Wnt Proteins | 2019 |